共 75 条
[1]
Mancuso A(2006)Current therapies and advances in the treatment of pancreatic cancer Crit Rev Oncol Hematol 58 231-241
[2]
Calabrò F(1997)Improvements in survival and clinical benefit with gemcitabine as first-line chemotherapy for patients with advanced pancreatic cancer: a randomized trial J Clin Oncol 15 2403-2413
[3]
Sternberg CN(2012)Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study) Cancer Chemother Pharmacol 69 1197-1204
[4]
Burris HA(2002)Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297 J Clin Oncol 20 3270-3275
[5]
Moore MJ(2002)Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic cancer Cancer 94 902-910
[6]
Andersen J(2002)Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study J Clin Oncol 20 1512-1528
[7]
Ozaka M(2007)Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trial Group J Clin Oncol 25 1960-1966
[8]
Matsumura Y(1996)Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602-2606
[9]
Ishii H(2008)A late phase II study of S-1 for metastatic pancreatic cancer Cancer Chemother Pharmacol 61 615-621
[10]
Berlin JD(2005)An early phase II study of S-1 in patients with metastatic pancreatic cancer Oncology 68 171-178